Literature DB >> 26784132

The Future of Glucose Monitoring.

Satish K Garg1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26784132      PMCID： PMC4717496          DOI： 10.1089/dia.2015.0421

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN： 1520-9156            Impact factor:   6.118


× No keyword cloud information.
  20 in total

1.  Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study.

Authors:  Satish Garg; Ronald L Brazg; Timothy S Bailey; Bruce A Buckingham; Robert H Slover; David C Klonoff; John Shin; John B Welsh; Francine R Kaufman
Journal:  Diabetes Technol Ther       Date:  2012-02-08       Impact factor: 6.118

2.  Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial.

Authors:  Satish Garg; Howard Zisser; Sherwyn Schwartz; Timothy Bailey; Roy Kaplan; Samuel Ellis; Lois Jovanovic
Journal:  Diabetes Care       Date:  2006-01       Impact factor: 19.112

3.  Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study.

Authors:  Timothy S Bailey; Howard C Zisser; Satish K Garg
Journal:  Diabetes Technol Ther       Date:  2007-06       Impact factor: 6.118

4.  A primary care perspective on the use of continuous glucose monitoring in clinical practice.

Authors:  Manisha Bhide; Jessica M S Grey; Emily G Moser; Satish K Garg
Journal:  Diabetes Technol Ther       Date:  2013-06-20       Impact factor: 6.118

5.  Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections.

Authors:  David Rodbard; Lois Jovanovic; Satish K Garg
Journal:  Diabetes Technol Ther       Date:  2009-12       Impact factor: 6.118

6.  Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes.

Authors:  S K Garg; R O Potts; N R Ackerman; S J Fermi; J A Tamada; H P Chase
Journal:  Diabetes Care       Date:  1999-10       Impact factor: 19.112

7.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

8.  Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes.

Authors:  Satish K Garg; Sherwyn Schwartz; Steven V Edelman
Journal:  Diabetes Care       Date:  2004-03       Impact factor: 19.112

9.  Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines.

Authors:  Jamie R Wood; Kellee M Miller; David M Maahs; Roy W Beck; Linda A DiMeglio; Ingrid M Libman; Maryanne Quinn; William V Tamborlane; Stephanie E Woerner
Journal:  Diabetes Care       Date:  2013-01-22       Impact factor: 19.112

10.  Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical trial.

Authors:  B W Bode; J B Buse; M Fisher; S K Garg; M Marre; L Merker; E Renard; D L Russell-Jones; C T Hansen; A Rana; S R Heller
Journal:  Diabet Med       Date:  2013-06-17       Impact factor: 4.359
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.